Diet, obesity and health economics I nsights from the Netherlands - - PowerPoint PPT Presentation

diet obesity and health economics
SMART_READER_LITE
LIVE PREVIEW

Diet, obesity and health economics I nsights from the Netherlands - - PowerPoint PPT Presentation

Diet, obesity and health economics I nsights from the Netherlands Tommy LS Visscher I mpact of obesity MORBI DI TY ZIEKTE MORTALI TY O Cardiovascular diseases B E S Type 2 diabetes mellitus I T Y Musculoskeletal disorders DI SABI LI


slide-1
SLIDE 1

Diet, obesity and health economics

I nsights from the Netherlands

Tommy LS Visscher

slide-2
SLIDE 2

I mpact of obesity

ZIEKTE

Musculoskeletal disorders

O B E S I T Y

Type 2 diabetes mellitus Cardiovascular diseases MORBI DI TY MORTALI TY DI SABI LI TI ES

Visscher TLS, Seidell JC. Annu Rev Publ Health 2001; 22:355-75

slide-3
SLIDE 3

I mportant measures

  • Prevalence rates
  • Relative risks
  • Population Attributable Fraction
slide-4
SLIDE 4

Obesity prevalence around 2000

  • USA:

28-33%

Flegal et al JAMA 2002

  • England:

17-22%

Health survey for England 1998.

  • Finland:

20-21%

Lahti-Koski et al Int J Obes 2001

  • Germany:

19-21%

Bergmann et al. Gesundheidswesen 1999

  • Netherlands:

10%

Visscher et al IJO 2002/2004

slide-5
SLIDE 5

Obesity in the Netherlands

slide-6
SLIDE 6

Obesity in the Netherlands

slide-7
SLIDE 7

Obesity in the Netherlands

slide-8
SLIDE 8

Obesity in the Netherlands

slide-9
SLIDE 9

Obesity in the Netherlands

slide-10
SLIDE 10

Obesity in the Netherlands

slide-11
SLIDE 11

Obesity in the Netherlands

slide-12
SLIDE 12

Obesity in the Netherlands

Visscher, Seidell, Kromhout Int J Obes 2002;26:1218-24 4 5 6 7 8 9 10

%

1976-80 1987-91 1993-97 age 37-43 jaar Men Women

slide-13
SLIDE 13

Obesity in the Netherlands

Statistics Netherlands

5 10 15 1 9 8 1 1 9 8 3 1 9 8 5 1 9 8 7 1 9 8 9 1 9 9 1 1 9 9 3 1 9 9 5 1 9 9 7 1 9 9 9 jaar % cbs-women cbs-men

slide-14
SLIDE 14

Obesity and educational level

period: 1993/97, age: 20-59 years

5 10 15 20 low middle high % men women

Visscher, Seidell, Kromhout Int J Obes 2002

slide-15
SLIDE 15

Obesity and age

period: 1993-1997

5 10 15 20 20-29 30-39 40-49 50-59 Age (years) % men w omen

Visscher, Seidell, Kromhout Int J Obes 2002

slide-16
SLIDE 16

Overweight and obesity in Dutch girls

2 4 6 8 10 12 14 16 6 12 18 Age 1980 1997

Fredriks et al Arch Dis Child 2000, Hirasing NtvG 2001

%

slide-17
SLIDE 17

Obesity and age

5 10 15 20 25 30 35 16-24 25-34 35-44 45-54 55-64 65-74 >75 Age (years)

prevalence of obesity (%)

men women

Health Survey for England 1997 Figure from: Seidell & Visscher. Eur J Clin Nutr 2000

slide-18
SLIDE 18

Behavioural determinants Energy-intake Energy expenditure Body weight Energy-balance

Weight gain

slide-19
SLIDE 19

Food intake (The Netherlands 1988-1998)

  • Saturated fat

+ (favourable)

  • Tans-fatty acids

+

  • Fish

+

  • Fruits
  • (unfavourable)
  • Vegetables
  • VCP / Van Kreijl 2004 RIVM
slide-20
SLIDE 20

Sugared softdrinks boys (13-18)

50 100 150 200 250 300 350 400 450 500 1987/ 88 1992 1997/ 98 g per day fruit juice soft-drinks

Source: VoedselConsumptiePeiling

slide-21
SLIDE 21

Relative risks

US women from the Nurses’ Health Study

Figure from Visscher et al Annu Rev Publ Health 2001

slide-22
SLIDE 22

Relative risks

  • Higher for morbidity than for mortality

Visscher Annu Rev Publ Health 2001, Visscher Arch Int Med 2004

  • Decrease with ageing Stevens NEJM 1999, Visscher Arch Int Med 2004
slide-23
SLIDE 23

Population attributable fraction

  • Prevalence rate
  • Relative risks
slide-24
SLIDE 24

Population attributable fraction - BMI ≥30 Men Women

  • Diabetes

26.3 52.9

  • Hypertension

12.0 23.5

  • CHD

4.1 17.4

  • Stroke

5.5 2.8

Dutch Health Council

slide-25
SLIDE 25

Costs – obesity – The Netherlands

Men Women

  • Calculated from PAF

0.8% 1.3

Source: Dutch Health Council and www.kostenvanziekten.nl; Calculated for Lipgene

slide-26
SLIDE 26

Costs underestimated

  • Not all consequences
  • Not age-specific:

– prevalence rate – Relative risks – absolute risk

slide-27
SLIDE 27

Costs – obesity – The Netherlands - 1989

Million Euro’s BMI ≥25

BMI ≥30

General practitioners 46 12 Medical specialists 37 14 Hospital admissions 225 81 Medication 250 67 Total attributable to obesity: 558 174 % Direct health care costs

4% 1%

Seidell IJO 1995

slide-28
SLIDE 28

Costs – obesity – The Netherlands

Million Euro’s Overweight (BMI ≥25 ) 558 Obesity (BMI ≥30) 174

Seidell IJO 1995

Overweight (BMI ≥25 ) 505

Polder 1999 RIVM

Diabetes II 430 Hypertension 433 Stroke 1029 MI 929

www.kostenvanziekten.nl

slide-29
SLIDE 29

Costs of obesity

Direct

  • USA: 6%

Wolf AM, Colditz GA. Obes Res 1998

  • Europe: 1-5%
  • Netherlands: 1%

Seidell JC. Int J Obes;1995

Indirect

  • Loss of productivity : 10%

Narbro K, et al. Int J Obes 1996

slide-30
SLIDE 30

Obesity and work disabilty

0.5 1 1.5 2 2.5

<22.5 22.5-24.9 25.0-27.4 27.5-29.9 30.0-32.4 >32.5

body mass index (kg/m2) Relative risk women men

Rissanen, BMJ 1990

slide-31
SLIDE 31

I mpact of obesity

ZIEKTE

Musculoskeletal disorders

O B E S I T Y

Type 2 diabetes mellitus Cardiovascular diseases MORBI DI TY MORTALI TY DI SABI LI TI ES

Visscher TLS, Seidell JC. Annu Rev Publ Health 2001; 22:355-75

slide-32
SLIDE 32

Is health promotion cost-effective?

slide-33
SLIDE 33

Outcome measures

Life-years lost

  • Healthy life-years
  • Quality of Life
  • DALY’s - QUALY’s
  • Compression of morbidity
slide-34
SLIDE 34

Health promotion cost-effective?

Vita, NEJM 1998

– Less lifetime disability – Less disability at any given age Prevention: less lifetime disability

Lubitz, NEJM 2003

– Health promotion improves health and longevity of the elderly without increasing health expenditures

slide-35
SLIDE 35

Health promotion cost-effective?

Vita, NEJM 1998

– Less lifetime disability – Less disability at any given age Prevention: less lifetime disability

Lubitz, NEJM 2003

– Health promotion improves health and longevity of the elderly without increasing health expenditures

Barendregt, NEJM 1997

– Smoking cessation: increased direct health care costs

slide-36
SLIDE 36

Deaths attributable to obesity (USA)

  • 112,000 (Year 2000) Flegal JAMA 2005
  • 414,000 (Year 2000) Mokdad JAMA 2004/2005
  • 280,000 (Year 1991) Allison JAMA 1991

Confidence interval around 112,000: 54,000 – 170,000

Mark JAMA 2005

slide-37
SLIDE 37

Costs: mortality versus morbidity

Direct health care costs 25% reduced when obesity- mortality relation is taken into account

Allison: AJPH 1999

slide-38
SLIDE 38

Lost life-years

  • BMI ≥30 at age 40 years:

6-7 years

Peeters Ann Int Med 2002

  • BMI >33 from age 40 years:

2-3 years

Fontaine JAMA 2003

  • BMI ≥30 at age 40 years:

0.8 years

Van Kreijl 2004 RIVM

  • BMI >30, age 37-43 years, 25 years: 0.2 years

Visscher ECO 2005 Athens

slide-39
SLIDE 39

Obesity / nutrition

  • BMI ≥30 at age 40 years:

0.8 years

Van Kreijl 2004 RIVM

  • Unhealthy food pattern at age 40:

1.2 years

Van Kreijl 2004 RIVM

  • BMI ≥30:

215,000 DALY’s per year

Van Kreijl 2004 RIVM

  • Unhealthy food pattern:

245,000 DALY’s per year

Van Kreijl 2004 RIVM

slide-40
SLIDE 40

Unhealthy life-years

HEALTHY UNHEALTHY BASELINE MORBIDTY MORTALITY

slide-41
SLIDE 41

Relative risks

US women from the Nurses’ Health Study

Figure from Visscher et al Annu Rev Publ Health 2001

slide-42
SLIDE 42

Unhealthy life-years

10% weight loss in those aged 35-64 years: – 1.2-2.9 fewer life-years with hypertension – 0.5-1.7 fewer life-years with diabetes II

Oster AJPH 1999

slide-43
SLIDE 43

Unhealthy life-years: empirical approach

  • Mortality
  • Work disability
  • Coronary Heart Disease
  • Chronic medication

HEALTHY UNHEALTHY 15 BASELINE MORBIDTY MORTALITY

slide-44
SLIDE 44

Unhealty life-years

Social Insurance Instution’s Mobile Clinic Study (Helsinki) An adult obese Finn during 15 years:

  • Half a year longer

Work disability

  • Half a year longer

Coronary heart disease

  • One and a half year longer

Chronic medication

Visscher TLS et al Arch Int Med 2004

slide-45
SLIDE 45

I mpact of obesity

ZIEKTE

Musculoskeletal disorders

O B E S I T Y

Type 2 diabetes mellitus Cardiovascular diseases MORBI DI TY mortality DI SABI LI TI ES

Visscher TLS, Seidell JC. Annu Rev Publ Health 2001; 22:355-75

slide-46
SLIDE 46

Cost-effective?

  • Prevention more efficient than treatment

Russell IJO 1995

  • Which age-category?

Seidell 2005 Boyd Orr

slide-47
SLIDE 47

Which age-category?

Children?

  • Relative risks high Stevens NEJM 1999, Visscher Arch Int Med 2004
  • Behaviour and habits are learnt at young age (?)
  • If successful, long term effect
slide-48
SLIDE 48

Which age-category?

Adults?

  • Sharpest increase in incidence of obesity in adulthood
  • Absolute risk and PAF increase with age
  • Intervention at young and older adults affect more

age-categories

slide-49
SLIDE 49

Cost-effective?

  • Prevention more efficient than treatment

Russell IJO 1995

  • Which age-category?

Seidell 2005 Boyd Orr

  • Effective? Evidence needed

Swinburn Obesity Reviews 2005

slide-50
SLIDE 50

Conclusions

  • Obesity prevalence is increasing in the Netherlands
  • PAF calculations are hard:
  • prevalence estimations, - relative risks, - subgroups
  • Cost calculations are hard:
  • Morbidity, - mortality
slide-51
SLIDE 51

Conclusions

  • Direct costs moderate overweight higher than costs obesity
  • Direct costs comparable to hypertension, diabetes II
  • Direct costs in the Netherlands

4% (BMI ≥25) / 1% (BMI ≥30)

  • Indirect costs: 10%
slide-52
SLIDE 52

Conclusions

  • Obesity more strongly related to morbidity and disability

than to mortality

  • Obesity related to UNHEALTHY life-years
slide-53
SLIDE 53

Conclusions

  • Obesity more strongly related to morbidity and disability

than to mortality

  • Obesity related to UNHEALTHY life-years
  • Further increase obesity will clearly lead to increased

costs

  • Weight gain prevention is essential in reducing health

care costs

slide-54
SLIDE 54

Thank you for your attention!

Tommy.Visscher @ falw.vu.nl